Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 28, 2010

Repligen Strikes Five-Year Extension to Supply Protein A to GE Healthcare

  • Repligen entered into a five-year supply agreement with GE Healthcare for recombinant Protein A, a consumable used in the manufacture of mAbs. This agreement provides for Repligen to continue to be a strategic supplier to GE Healthcare through 2014.

    GE Healthcare sells chromatography products that incorporate Repligen's recombinant Protein A to the biopharmaceutical industry for the manufacture of mAbs.



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »